Patrick Bell, CEO and Director of Finexia Financial Group (ASX:FNX) speaks to Garry Crole, CEO and Managing Director of Sequoia Financial Group (ASX:SEQ). Topics discussed include the company's Childcare Income Fund and its lending business.
Copyright 2024 – Finance News Network
26 Sep 2019 - First Graphene Limited (ASX:FGR) Executive Director and CFO, Peter Young talks about the company's worldwide licensing agreement with the University of Manchester for its technology used in supercapacitors.
23 Sep 2021 - AD1 Holdings Limited (ASX:AD1) CEO and Managing Director Brendan Kavenagh provides an update on the company's suite of software as a service businesses, FY21 results and outlook.
17 Mar 2022 - Managing Director Kym Winter-Dewhirst talks about Venice Energy's plans to develop the world’s first LNG import facility entirely powered by renewable energy. The LNG Import and Storage terminal will be located at Outer Harbor, around 14km from Adelaide, and has been designated as “essential infrastructure” by the South Australian State Government.
15 Aug 2024 - Forbidden Foods Limited (ASX:FFF) CEO and Managing Director Alex Aleksic provides an introduction to the company, discussing its recent acquisition of Good Oats.
01 Jun 2020 - OncoSil Medical Limited (ASX:OSL) Managing Director and CEO Daniel Kenny talks about the significance of the company's CE Marking approval for its lead product OncoSil, which helps treat pancreatic, liver and biliary duct cancer.
21 Mar 2023 - Aspen Group Limited (ASX:APZ) Executive Director and Joint CEO John Carter provides an introduction to the company, discussing target market, the rising interest rate environment, portfolio mix and development pipeline.
04 Mar 2024 - Andrew Penkethman - Managing Director and CEO - Ardea Resources (ASX:ARL) is advancing its flagship 100%-owned Kalgoorlie Nickel Project (KNP). KNP is the largest Nickel–Cobalt resource in Australia and in the top 10 globally, making it of a scale that is incredibly rare and important in the World’s journey to Net Zero. KNP was awarded Major Project Status by the Australian Federal Government, recognising the national and strategic significance of the KNP to the Australian...
09 Dec 2020 - Alterity Therapeutics Limited (ASX:ATH) Chairman and CEO Geoffrey Kempler provides an update on the company's lead compound ATH434 for Multiple System Atrophy, its dual strategy in Europe and the US and its Phase 2 plans.